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Kir channels serve diverse and important roles throughout the human body and 
malfunctions of these channels are implicated in various channelopathies. Specific 
inhibitors for different subtypes of Kir channels are not available. However, Tertiapin-Q 
(TPNQ), a polypeptide isolated from honey bee venom, differentially inhibits certain 
subtypes of Kir channels with nanomolar affinity: ROMK1 (Kir1.1) and GIRK1/GIRK4 
(Kir3.1/Kir3.4). Modification of TPNQ to increase selectivity for target channels bears 
great therapeutic potential. The in silico studies based on TPNQ-docked channel models, 
ROMK1_IRK2 (Kir1.1_Kir2.2) and GIRK2 (Kir3.2), predicted specific paired residue 
interactions and were experimentally validated here. In ROMK1 E123A mutant, the 
TPNQ sensitivity was decreased by ~2-fold while GIRK2 E127A mutant reduced the 
TPNQ sensitivity by greater than 10-fold. Also, we could observe the additional effect, ~ 
18 fold, of GIRK1 subunits, ~1.7 fold, and E127A mutation, ~10 fold, on the TPNQ 
sensitivity in the heteromeric mutant channel, GIRK1/GIRK2 E152D_E127A as 
compared with the homomeric GIRK2 E152D. Finally, we introduced the Kir3.2 E152D 
mutant as a good representative of wild-type behavior particularly for the TPNQ study. 
Overall, this type of structure-function studies suggests an efficient and cost effective 
way toward design and development of specific Kir channel blockers by targeting on 
specific paired interactions between TPNQ and the Kir channels. 
 
 
 
 
 
 
 
	   1	  
INTRODUCTION 
	   Ion channels are macromolecular transmembrane protein complexes that facilitate 
the ion movement across the membrane lipid bilayer. They are essential to all kinds of 
living organisms and are highly conserved from prokaryotes to mammals. The net ion 
movement across membranes serves many biological functions such as regulating the 
membrane potential, osmotic balance, and pH. Moreover, their activity has been known 
to contribute to cellular homeostasis and maintenance of health in many areas of the 
human body. More than 40 different channelopathies had been identified up to 5 years 
ago, and modulating channel activity by drugs is widely used to treat channelopathies 
(Cannon, 2007). Thus, ion channels are one of the largest class of proteins intensely 
investigated by pharmaceutical industries. 
In this study, we are focusing on the inwardly rectifying K+ (Kir) channels, first 
identified half a century ago (Katz, 1949). cDNAs of the first two Kir channels, Kir1.1 
(ROMK1) and Kir2.1 (IRK1), were isolated by expression-cloning techniques in 1993 
(Kubo, 1993; Ho, 1993). The major biological roles of Kir channels are to maintain the 
resting membrane potential and to regulate the action potential duration in electrically 
excitable cells such as cardiac muscle (Sakmann, 1983), but some Kir channels also play 
vital roles in other types of tissues such as ROMK1 in kidney. Their defining 
characteristic, inward rectification is known to be due to the block of outward K+ flux by 
intracellular substances such as Mg2+ and polyamines (Lopatin, 1995; Matsuda, 1987). 
The common basic building block of all Kir channels consists of two membrane spanning 
domains (M1 and M2) linked by a highly conserved extracellular pore forming region (P) 
and cytoplasmic amino (N)- and carboxy (C)- terminal domains (Figure 1A). The 
functional Kir channels are composed of four such subunits as a tetrameric complex 
(Yang, 1995). The tetrameric complex can be formed either by association of homomeric 
or heteromeric subunits. So far, 15 Kir subunit genes have been identified and classified 
into seven subfamilies, also categorized into four functional groups. 
	   2	  
 
Figure 1. Structural details of Kir channels and channel blocker TPNQ A. Topology of Kir in cartoon 
representation where, M1 and M2 are the outer and inner transmembrane helices respectively, and P is the 
pore helix. N and C indicate the N- and C-termini regions of the Kir.  B. Sequence alignment of 3 TPN-
sensitive Kir channels (Kir1.1 or ROMK1, 2 isoforms of Kir3.2 or GIRK2 and Kir3.4 or GIRK4) and 3 
TPN-insensitive Kir channels (Kir3.1 or GIRK1, Kir2.2 or IRK2, and Kir2.1 or IRK1) (M1 to M2 linker 
alignment is shown). The grey regions are conserved regions of Kir channels and the yellow highlighted 
residues are predicted to be important in the interactions of ROMK1 with TPNQ. The underlined labels are 
those for which we have either a homology model or a crystal structure. C. NMR structural model (Xu and 
Nelson, 1993) of TPN showing the 21 residues and the two-disulphide (3-14; 5-18) linkages from the 
RCSB protein data bank: 1TER (www.rcsb.org). D. TPNQ docked chimeric ROMK1_IRK2 tetrameric 
channel based on the cKir2.2 crystal structure (Tao et al., 2009), (E) TPNQ docked GIRK2 tetrameric 
channel (Whorton et al., 2011). Only two subunits of the tetrameric channel are shown for clarity. This 
figure was generated by Dr. Sundaram (Sundaram et al., In Preparation). 
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  In terms of their physiological functions, Kir channels serve diverse and important 
roles throughout the human body and malfunctions of these channels are implicated in 
various diseases. For example, Kir1.0, also called ROMK, is predominantly expressed in 
the kidney and is important in maintaining K+ homeostasis. Genetic defects of this 
channel can lead to type II Barter’s syndrome with volume depletion and hypotension 
(Simon, 1996). Kir 3 or G-protein coupled inward rectifier (GIRK) channels are 
expressed primarily in the brain and heart as either homo- or hetero- tetrameric 
complexes. In brain where all of GIRK1-GIRK4 are expressed, activation of GIRK 
channels is involved in the inhibitory actions of various neurotransmitters such as GABA, 
ACh, and opioid peptides, and mice lacking GIRK2 are known to be more susceptible in 
developing seizures (Abraham, 1999). Moreover, a heterotetramer of GIRK1/GIRK4 
forms the KACh channel, which mediates vagal control of pacemaker activity 
(Krapivinsky, 1995). Therefore, specific inhibitors for different subtypes of Kir channels 
would be very useful for studying their physiological functions and also for designing 
drugs to treat channelopathies. However, no Kir subtype specific inhibitors are available. 
To date, tertiapin (TPN) is the only reported nanomolar-affinity inhibitor that 
differentially inhibits certain subtypes of Kir channels, such as Kir1.1 or ROMK1 (Kd = 
1~2.5 nM) (Ho, 1993; Jin and Lu, 1998), heteromeric Kir3.1/Kir3.4 or GIRK1/GIRK4 
(Kd = 10 nM) (Kubo, 1993; Dascal, 1993; Krapivinsky, 1995).  Kir2.1 or IRK1 on the 
other hand have much lower affinity for this peptide toxin (Kd = 2 µM) (Jin and Lu, 
1998). TPN, isolated from the honey bee venom, is a small compact protein composed of 
21 amino acids (Gauldie et al., 1976; Ovchinikov et al., 1980).  Its C-terminal half forms 
an α-helix, while its N-terminal half forms an extended structure.  Two disulfide bonds 
hold these two structures together (Xu and Nelson, 1993) (Fig. 1C). The methionine 
residue in position 13 is easily oxidized, and a glutamine mutation at this position 
prevents oxidation and is more stable.  Tertiapin-Q or TPNQ shows no functional 
differences from the native TPN and exhibits an even higher selectivity (Jin and Lu, 
1999). 
 TPN binds to the channel in one to one stoichiometry, so that one TPN peptide 
interacts with the Kir channel that is composed of 4 subunits (Jin et al., 1999). The 
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blocking effect of TPN is sensitive to pH, such that alkaline pH reduces the affinity 
between the toxin and Kir1.1 (Ramu et al., 2001). In addition, alanine scanning 
mutagenesis studies on Kir1.1 and TPNQ have shown that the C-terminal α-helix of 
TPNQ binds to the external vestibule of the K+ conduction pore formed by the M1-M2 
linker (Jin et al., 1999). This is also inferred from the chimeric studies by Lu’s group that 
transferring the M1-M2 linker of a TPNQ sensitive channel, Kir1.1, to a non-sensitive 
channel, Kir2.1, confers TPN sensitivity to the chimeric channel (Ramu et al., 2004).  
 Motivated by the above chimeric studies and the availability of Kir2.2 or IRK2 
crystal structure (Tao et al., 2009) which is also TPNQ insensitive, Dr. Shobana 
Sundaram in our lab built a computational chimeric model by transplanting the M1-M2 
linker of Kir1.1 in the background of Kir2.2 (Fig. 1D). With this chimeric model, Dr. 
Sundaram simulated an alanine scanning mutagenesis in silico and was able to regenerate 
the similar trend of the experimental data, which illustrates the changes in the binding 
interaction between channel and the toxin, shown by the Lu’s group (Jin et al., 1999). 
Moreover, while Lu’s data only show how one mutation affects function by changing 
macromolecular interactions (whole channel and toxin interactions), our in silico studies 
could quantify the energies involved for each channel-toxin interaction pair. Namely, it 
can specifically identify the toxin and channel interacting residues and quantify their 
interaction energy (Fig. 2A).  
Dr. Sundaram’s simulations and calculations on overall energy of interactions 
between TPNQ and ROMK1 chimera were in close agreement with the experimental data 
from Zhe Lu’s lab and her calculations of specific pairwise interactions of ROMK1 
chimera with TPNQ residues showed direct interactions between residues in the channel 
and the toxin (Fig. 2A). By using mutagenesis and whole-cell current recording with two-
electrode voltage clamp (TEVC), we validated the predictions of the paired interactions 
to see how much mutation of the predicted residues, E123A and E151A, could affect 
TPNQ sensitivity. In addition, since the crystal structure of GIRK2 had been recently 
determined by Mackinnon’s group (Whorton, 2011), we performed similar in silico 
studies on TPNQ docked GIRK2 model (Fig. 1E; Fig. 2B) and validated them using the 
same approach used for the Kir1.1 chimeric model. Our study suggests that differences in 
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the interaction energies can guide the design of a specific TPN blocker for the channel of 
interest in an efficient and cost effective manner. 
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Figure 2. Studies on paired interacting residues between TPNQ and A. ROMK1_IRK2 chimeric 
channel B. GIRK2 channel.  The list of interacting residue pairs between TPNQ and the subunits of the 
channel and their interaction energies in Kcal. The yellow color highlights the residues of TPNQ and the 
channel and the highest interaction energies. This figure was generated by Dr. Sundaram (Sundaram et al., 
In Preparation). 
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MATERIALS AND METHODS 
Characterization of channel mutants in the Xenopus laevis oocyte system and their 
interaction with TPNQ were studied experimentally using the two-electrode voltage 
clamp (TEVC) technique.  
In vitro transcription of cRNAs 
cDNA constructs of Kir1.1, Kir3.2, Kir3.2 E152D, Gβ1, and Gγ2 had previously 
been subcloned into oocyte expression vectors, pGEM-HE (Kir1.1, Gβ1, and Gγ2) or 
pXOOM (Kir3.2 and Kir3.2 E152D) by previous laboratory members in order to generate 
transcripts for expression in Xenopus laevis oocytes. The constructs were amplified using 
supercompetent XL1-Blue E. coli (Stratagene, La Jolla, CA) and isolated using a 
miniprep kit (Fermentas, Glen Burnie, MD). 
Prior to cRNA in vitro transcription, amplified cDNA subcloned vectors were 
linearized with NheI (Kir1.1, Gβ1, and Gγ2) or Xho1 (Kir3.2 and Kir3.2 E152D) digestion 
overnight at 37°C. cRNAs were in vitro transcribed using T7 polymerase (Ambion, 
Austin, TX). cRNA concentration was quantified by optical density.  
Xenopus laevis oocyte injection 
Xenopus oocytes were surgically extracted, dissociated and defolliculated by 
collagenase treatment, then microinjected with 50 nl of a water solution containing the 
desired cRNAs. The homotetramer constructs used in this study were injected to achieve 
10 ng/oocyte (Kir3.2 wild-type, Kir3.2E127A, Kir3.2E152D, and Kir3.2E152D_E127A) 
or 1 ng/oocyte (Kir1.1 wild-type, Kir1.1E123A, and Kir1.1E151A). Heterotetramer 
constructs used in this study were coinjected to achieve 2 ng/oocyte (Kir3.1/Kir3.2 wild-
type, Kir3.1/Kir3.2 E127A, Kir3.1/Kir3.2 E152D, and Kir3.1/Kir3.2 E152D_E127A) or 1 
ng/oocyte (Kir1.1/Kir1.1 E123A and Kir1.1/Kir1.1 E151A) for each subtype. For studies 
involving Gβγ, cRNAs of each subunit were coinjected to achieve 2 ng/oocyte. Oocytes 
were incubated for 1-3 days at 18 °C. 
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Injection pipettes were made from borosilicate glass (WPI, Saratosa, FL) using a 
Sutter P-97 microelectrode puller and were manually cut to produce tips of ~12 mm in 
diameter.  
Mutagenesis 
cDNAs for Kir1.1, Kir3.2, and Kir3.2 E152D were already subcloned into an 
oocyte expression vector, pGEM-HE or pXOOM. Desired mutations were introduced by 
the commercial Quickchange (Agilent Technologies) method.  Briefly, complimentary 
primers containing and centered about the desired mutation were designed.  PCR was 
carried out using the pfu polymerase and was allowed to cycle only 18 times to avoid 
errors.  All mutants were confirmed by DNA sequencing (Genewiz).     
Electrophysiology 
Whole-cell recordings were made 24-30 hours (Kir1.1 channels) or 72-80 hours 
(Kir3.2 channels) after cRNA injection using conventional two-electrode voltage clamp 
with a GeneClamp 500 amplifier (Axon Instruments). Agarose cushion microelectrodes, 
filled with 1% agarose in 3 M KCl to prevent leakage of KCl into oocytes, were used 
with resistances between 0.1 and 1.0 MΩ.  All channel currents were recorded in high 
potassium (ND96K) solution. 
The membrane was held at the equilibrium potential, namely at 0 mV. In order to elicit 
current through the channel, the membrane voltage was stepped to -90 mV and then to 
+90 mV for one-second intervals. Current at -90 mv was recorded.  Barium-sensitive 
basal currents were defined as the difference between the steady-state currents, while 
perfusing high potassium (High K+ or ND96K) solution, and the same solution 
containing 3mM barium chloride solution. 3 mM barium chloride containing ND96K 
solution was used for complete block of the Kir currents. Leak currents were considered 
as the remaining inward currents after exposure to 3 mM barium chloride and subtracted 
from the total currents measured in High K+ solution and each TPNQ concentration. 
Various concentrations of TPNQ were diluted in ND96K and oocytes were perfused with 
ND96K with or without TPNQ.  
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The ND96K solution contained: 91mM KCl, 1mM NaCl, 1mM MgCl2, 5mM 
KOH/HEPES, pH 7.4.  The Barium solution consisted of ND96K + 3mM BaCl2.  4-12 
oocytes from the same batch were recorded for each TPNQ concentration and the 
experiments were repeated in at least two batches.   
Statistical analysis 
All current values in response to 100 ms steps at -90 mV were obtained using 
Clampfit 9.2 (Molecular Devices, Sunnyvale, CA) and transferred to Excel software 
(Microsoft, Albuquerque, NM). For each oocyte, 10 data points of the steady-state 
currents in High K+ solution, each TPNQ concentration, and 3 mM barium chloride were 
selected and averaged and then subtracted from the leak currents, except for the currents 
in 3 mM barium chloride, used to obtain the basal current in ND96K with or without 
TPNQ. Then, each mean current for the corresponding TPNQ concentrations was 
normalized by dividing it by the maximal basal current in ND96K without TPNQ. These 
mean currents were averaged again with other mean currents at the same TPNQ 
concentration obtained from other oocytes from the same and different batches. The 
mean current values for each TPNQ concentration with the standard error of the mean 
(SEM) were transferred into MicroCal Origin Lab and plotted and fitted with a non-linear 
Growth/Decay/Sigmoidal Curve governed by the Hill function.  The Hill function is 
given by the equation: y = Start + (End - Start)*x^h/(K^h+x^h)). Start is where the curve 
starts, fixed to 1, and End is where it ends, fixed to 0. x is the TPNQ concentration. K is 
approximated as the IC50 for the binding reaction. h is the Hill coefficient. n ≥ 4 
experiments were used for estimating each data point in the dose-response curve. Error 
bars in the figures represent standard error. The standard deviations for each data set were 
divided by the square root of the number of recordings to get the standard errors. The 
two-sample t test (ROMK1: n= 13 for wild-type, 12 for E123A, 9 for E123A coinjected, 
and 12 for E151A coinjected, GIRK2: n= 11 for wild-type, 13 for E152D, 13 for 
GIRK1/GIRK2, 12 for GIRK1/GIRK2 E152D, 11 for GIRK2 E152D_E127A, 9 for 
GIRK1/GIRK2 E152D_E127A) was used to assess statistical significance. 
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RESULTS 
TPNQ Sensitivities of ROMK1 (Kir1.1) Wild-type Channel 
 We first examined the apparent affinity of ROMK1 (Kir1.1) for TPNQ in order to 
compare our results to previously published work. Xenopus oocytes were injected with in 
vitro transcribed rat ROMK1 cRNA, and membrane currents were recorded 24-30 hours 
later using two-electrode voltage clamp (TEVC). In symmetrical 96 mM potassium 
solutions, ND96K (High K+), the membrane was held at the equilibrium potential, 
namely at 0 mV. In order to elicit current through the channel, the membrane voltage was 
stepped to -90 mV and then to +90 mV for one-second intervals.  This protocol allowed 
us to monitor the characteristic rectification of Kir1.1 and immediately detect changes in 
leak currents, the remaining inward currents after exposure to 3 mM barium chloride. 
Various concentrations of TPNQ were diluted in ND96K and oocytes were perfused with 
ND96K with or without TPNQ. 3 mM Barium Chloride in ND96K solution was used for 
complete block of Kir1.1 currents.  
Each solution was perfused until the current reached a steady state. In agreement 
with previous studies by Zhe Lu’s group (Jin and Lu, 1998; Ramu et al., 2004), we found 
ROMK1 to be the most sensitive channel to TPNQ. In our hands, ROMK1 showed an 
IC50 value of 8.07 nM ± SEM, which was used as our control to compare with other 
mutant channels. 
Effects of ROMK1 Mutations on TPNQ sensitivity 
 As predicted by in silico studies in Fig. 2A, we selected residues to mutate that 
showed the highest interaction energy values: Glutamate 123 and 151. Glutamate 123 
from two different subunits interacts with Lys 16, 17, and 21 on TPNQ, and Glutamate 
151 from one subunit interacts with Lys 17 on TPNQ. 
Fig. 3 shows the current traces of ROMK1 wild-type and its mutant channels, 
E123A and E151A, recorded in the presence and the absence of 10 nM TPNQ. IC50 
values were obtained using nonlinear curve fitting (Hill equation) based on the plots of 
the fraction of unblocked currents against the concentration of TPNQ, as illustrated for 
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the inhibition of ROMK1 and its mutant channels by TPNQ (Fig. 4A). The E123A 
mutation in ROMK1 significantly increased the IC50 by more than 2-fold as compared to 
the wild-type, which supports our computational prediction that the E123A mutation 
should cause a decrease in TPNQ sensitivity of ROMK1 channel (Fig. 4B) and is 
consistent with previous reports (Jin et al., 1999).  
ROMK1 with the E151A mutation did not express any detectable ionic currents 
(Fig. 4B), consistent with results from Zhe Lu’s group (Jin et al., 1999). Thus, we 
coinjected the E151A mutant cRNA with wild-type cRNA in one to one ratio to test 
whether coexpression of heterotetramers between mutant and wild-type shifted the IC50 
of the wild-type channel. Coinjected E151A mutant channels showed measurable ionic 
currents, approximately -19 µA, with less TPNQ sensitivity than that of the wild-type 
homomeric channels,  (Fig. 3C and Fig. 4B).  
In order to compare the effect of the two mutations on the channel interaction 
with TPNQ under identical conditions, a similar coinjection method was also conducted 
with the E123A mutant channels. Since E123 has a greater number of high energy 
interactions with TPNQ residues than E151, we expected a greater decrease in TPNQ 
sensitivity of ROMK1 by the E123A mutation than the E151A. However, our results 
contradicted with our expectations.  The coinjected E123A mutant channels did not show 
a statistically significant difference from the coinjected E151A mutant channels in TPNQ 
sensitivity (Fig. 3B). Furthermore, this coinjection method shows a titration of IC50 
values between wild-type and mutant channels, as illustrated by the E123A/wild-type 
mixtures (Fig. 4A and B). 
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Figure 3. Inhibition of ROMK1 and its mutant channels by 10 nM TPNQ. Representative current 
traces of A. ROMK1 wild-type B. ROMK1 E123A mutant C. Coinjected ROMK1 E151A mutant D. 
Coinjected ROMK1 E123A mutant. Currents through the channels were elicited by stepping the membrane 
potential from the equilibrium potential (0 mV) to -90 mV and then to +90 mV for one-second intervals. 
The black current trace indicates the maximum basal current in ND96K (High K+) solution and the red 
current trace indicates the remaining current in the presence of 10 nM TPNQ containing High K+ solution. 
The ROMK1 mutant channels, E123A or E151A, are coexpressed with ROMK1 wild-type channels by 
coinjecting their cRNAs in one to one ratio. Dotted lines indicate the zero current levels. 
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Figure 4. Summary comparison of TPNQ sensitivity of the ROMK1 wild-type and its mutant 
channels. A. Fraction of the unblocked channel currents (mean ± SEM., n ≥ 10) plotted against the TPNQ 
concentration. Leak currents, Barium insensitive currents, are subtracted from the each remaining current in 
the presence of various concentrations of TPNQ and then divided by the maximum basal currents in the 
absence of TPNQ in order to be normalized. The maximum basal currents were also subtracted from the 
leak currents prior to normalization. B. Summary bar graphs of IC50 values (mean ± SEM; N.D. indicates 
no detectable channel current). IC50 values were obtained using nonlinear curve fitting (Hill equation, see 
MATERIALS AND METHODS) based on the plots. Two sample t-tests were assessed to test for the 
significant difference in IC50 values of the ROMK1 mutant channels against the wild-type and also between 
two coinjected mutants (* indicates p<0.05, *** indicates p<0.001, n.s. indicates no significance).  
 
 
 
 
	   14	  
TPNQ Sensitivities of the GIRK2 (Kir3.2) Wild-type Channel 
Using the similar experimental conditions as in the previous ROMK1 studies, 
Xenopus oocytes were injected with in vitro transcribed mouse GIRK2 cRNA, and 
membrane currents were recorded 72-80 hours later using two-electrode voltage clamp 
(TEVC). In symmetrical 96 mM potassium solutions, ND96K (High K+), the membrane 
was held at the equilibrium potential, namely at 0 mV. In order to elicit current through 
the channel, the same voltage step protocol was used, -90 mV and then +90 mV steps for 
one-second intervals.  
In order to obtain the control for comparison studies with mutant channels, we 
first recorded the dose response of the GIRK2 wild-type channel to TPNQ. The IC50 was 
around 15 nM (Fig. 5). As described in a previous study (Yi et al., 2001), wild-type 
channels conduct small basal currents in High K+ solution, in our hands the mean current 
was approximately -0.87 µA (Fig. 6A) including leak, endogenous currents insensitive to 
Barium Chloride block that ranged from -0.2 to -0.5 µA (data not shown). Hence, 
distinguishing such small basal currents from GIRK2 wild-type channel expression from 
the background endogenous currents was quite challenging. 
Difficulties in Distinguishing the Basal Currents of the GIRK2 E127A Mutant from 
the Background Endogenous Currents  
According to Sundaram’s simulation studies on the TPNQ docked GIRK2 model 
(Fig. 2B), Glutamate 127 on all four subunits showed the highest interaction energy with 
the TPNQ residues: Arg7, Lys16, 17, 20, and 21. This model predicts that Glu127 is the 
main interacting residue on GIRK2 channel in direct-paired interactions with TPNQ.  
Fig. 5 shows the dose-responses of GIRK2 wild-type channel and its E127A 
mutant channel to TPNQ. However, since the basal currents of E127A mutant channel 
were very small, even smaller than that of wild-type channel (data not shown), it was not 
possible to distinguish the basal currents of the mutant channel from the background 
endogenous currents. Therefore, we could not obtain strong evidence to conclude that the 
reduction in TPNQ sensitivity was that of this expressed GIRK2 mutant (Fig. 5).  
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Figure 5. Inhibition of GIRK2 wild-type and its E127A mutant by TPNQ in a dose dependent 
manner. Fraction of the unblocked channel current of GIRK2 wild-type and its E127A mutant (mean ± 
SEM., n ≥ 4) plotted against the TPNQ concentration. The same normalization method was used as 
described in Fig. 4. Even though there was a decreasing trend against the various TPNQ concentrations 
shown in the Hill fitting in the GIRK2 E127A mutant, we could not confidently distinguish the true basal 
currents, ranging within a couple of hundred nA, from the background endogenous currents. 
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Figure 6. The E152D mutation enhances GIRK2 basal currents. Representative current traces of A. 
GIRK2 wild-type B. GIRK2 E152D. Currents through the channels were elicited with the same protocol 
described in Fig. 3. The black current trace indicates the maximum basal current in ND96K (High K+) 
solution. The red current trace indicates the remaining current in High K+ solution containing 10 nM 
TPNQ. Dotted lines indicate the zero current levels. C. Summary bar graphs of mean currents (mean ± 
SEM.). Approximately 20-fold enhancement in the basal currents is shown in the GIRK2 E152D current 
compared with that of the wild-type. 
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Thus, in an effort to enhance the currents of the mutant channel, we coinjected 
Gβγ cRNA. Gβγ has been shown to stimulate GIRK activity (Logothetis et al. 1987), and 
coexpression of Gβ1γ2 with GIRK subunits in Xenopus oocytes results in augmented 
currents (He et al., 1999). Fig. 8A clearly shows the enhancement in the basal currents of 
the GIRK2 wild-type channel by the Gβγ activation, while there appears to be no 
enhancement in the currents of the GIRK2 E127A mutant channel, which shows current 
levels similar to those of uninjected oocytes (Fig. 8B and E).  
The GIRK2 E152D Mutant shows similar sensitivity to TPNQ as the wild-type 
channel 
As previously described, these difficulties in distinguishing the basal currents of 
the mutant channels from the endogenous ones led us to use a pore helix mutant, GIRK2 
E152D, previously reported to enhance basal currents by about 20-fold (Yi et al., 2001). 
Based on single-channel recordings, it was shown that this mutation did not affect the 
single-channel conductance but profoundly changed single-channel kinetics such as the 
increases in open probability and mean open duration (Yi et al., 2001). This indicates that 
the mutation enhances GIRK2 currents by changing its gating properties.  
Large basal currents from expressed channels can be readily distinguished from 
endogenous background currents. Moreover, larger currents make it easier to detect 
changes in dose-response measurement. Therefore, if this pore helix mutant channel did 
not show any differences from the wild-type in TPNQ sensitivity, it could be used as a 
good representative of the GIRK2 wild-type channel in future studies with TPNQ.  
Consequently, we examined the GIRK2 E152D channel under identical 
experimental conditions used for the GIRK2 wild-type channels to directly compare to 
each other. In agreement with previous studies (Yi et al., 2001), we also obtained 
dramatically enhanced basal currents, about 20-fold (-20.25 µA), compared with those 
from wild-type channels, (-0.87 µA) (Fig. 6C). Comparison of TPNQ sensitivity from 
dose-response experiments showed no significant differences between the GIRK2 wild-
type and the E152D channel, IC50 = 14.82 nM and 18.3 nM, respectively (Fig. 7A and B).  
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Figure 7. Similarity in TPNQ sensitivity between the GIRK2 wild-type and the GIRK2 E152D 
mutant. A. Fraction of the unblocked channel currents (mean ± SEM., n ≥ 4) plotted against the TPNQ 
concentration. The same normalization method was used as described in Fig. 4. B. Summary bar graphs of 
IC50 values (mean ± SEM.). IC50 values were obtained using the same Hill fitting as described in Fig. 4. 
Two sample t-tests for significance between IC50 values of GIRK2 and GIRK2 E152D channels (n.s. 
indicates no significance), which justify the GIRK2 E152D mutant as a substitute of the wild-type in the 
TPNQ studies. 
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Figure 8. The basal current enhancement by the Gβγ activation on the homomeric GIRK2 and 
GIRK2 E152D in the presence and the absence of the E127A mutation. Representative current traces of 
A. GIRK2 wild-type B. GIRK2 E127A mutant C. GIRK2 E152D D. GIRK2 E152D_E127A mutant 
channels. All tested channels were coinjected with 2 ng of Gβ1 and 2ng of Gγ2 cRNAs. Currents through 
the channels were elicited with the same protocol as described in Fig. 3. The black current trace indicates 
the maximum basal current in ND96K (High K+) solution. The red current trace indicates the remaining 
current in High K+ solution contaning.100 nM TPNQ.  The grey current trace indicates the leak currents   
(currents remaining in the presence of 3 mM Barium Chloride). Dotted lines indicate the zero current 
levels. Summary bar graphs (mean ± SEM.) of the mean currents of E. GIRK2 wild-type and the E127A in 
the background of GIRK2 wild-type F. GIRK2 E152D and the E127A in the background of E152D, 
coexpressed with Gβγ. In both panels E and F uninjected oocytes were used as the negative control. Two 
sample t-tests were assessed to test for the significant difference between the mean currents of the GIRK2 
E127A mutant in the presence of High K+ solution and 100 nM TPNQ in panel E and between the mean 
currents of the GIRK2 E152D and the GIRK2 E152D_E127A in the presence of 100 nM TPNQ in panel F 
(* indicates p<0.05, n.s. indicates no significance).  
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Interestingly, Gβγ coexpression not only yielded huge measurable currents from 
the GIRK2 E152D_E127A mutant channel (Fig. 8D and F) but also showed a significant 
reduction of the TPNQ sensitivity of the E127A mutant channel (Fig. 8F).  
Therefore, these data gave us confidence to consider the GIRK2 E152D mutant as 
a good representative of TPNQ sensitivity of the GIRK2 wild-type channel. 
Effects of E127A mutation in the GIRK2 E152D background on TPNQ Sensitivity 
Fig. 9A and B shows the current traces of GIRK2 E152D and its E127A mutant 
channel. There is about a 2-fold decrease in the mean current between the two channels, 
which suggests that the E127A mutation causes a reduction in the basal currents, -9.59 
µA in the presence and -20.25 µA in the absence of the mutation (Fig. 9C). Moreover, as 
predicted by Sundaram’s simulations (Fig. 2B) and shown in the Gβγ tests (Fig. 8F), the 
E127A mutation remarkably reduced the TPNQ sensitivity by greater than 10-fold. The 
IC50 for the channels in the absence and presence of the mutation are, 18.3 nM and 
194.03 nM, respectively  (Fig. 10A and B). This supports our prediction that the E127 is 
a critical residue in the paired residue interactions between the GIRK2 channel and 
TPNQ. 
Effects of the GIRK1 subunits on the TPNQ sensitivity of GIRK2 channels 
In another study from Lu’s group (Ramu et al., 2004), chimeras between IRK1 
with GIRK4 or GIRK1 were constructed to identify which subunits contribute to the high 
affinity inhibition of TPNQ on the heteromeric GIRK1/GIRK4 channels. These 
investigators concluded that GIRK4 subunits were the major ones contributing to the 
TPNQ sensitivity in the heteromeric channels. 
We proceeded to conduct TPNQ dose-response studies with the heteromeric 
GIRK1/GIRK2 channels and predicted that the addition of GIRK1 subunits would reduce 
the TPNQ sensitivity of homomeric GIRK2 channels.  
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Figure 9. Reduction in the basal current by the E127A mutation in GIRK2 E152D channels. 
Representative current traces of A. GIRK2 E152D B. GIRK2 E152D with the E127A mutation. Currents 
through the channels were elicited with the same protocol as described in Fig. 3. The black current trace 
indicates the maximum basal current in ND96K (High K+) solution. The red current trace indicates the 
remaining current in High K+ solution containing 10 nM TPNQ. Dotted lines indicate the zero current 
levels. C. Summary bar graphs of mean currents (mean ± SEM.). Approximately 2-fold reduction was 
observed in the basal currents of GIRK2 E152D compared to the wild-type. 
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Figure 10. Effect of the E127A mutation on TPNQ sensitivity of Kir3.2 E152D channel. A. Fraction of 
the unblocked channel currents (mean ± SEM., n ≥ 4) plotted against the TPNQ concentration. The same 
normalization method was used as described in Fig. 4. B. Summary bar graphs of IC50 values (mean ± 
SEM.). IC50 values were obtained using the same Hill fitting as described in Fig. 4. Two sample t-tests were 
carried out to assess significant differences in IC50 values between the Kir3.2 E152D control and the 
E127A mutant (*** indicates p<0.001). 
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Fig. 11 shows the characteristic enhancement in the basal currents by the 
coexpression of GIRK1 and GIRK2 subunits as previously reported (Kofuji et al., 1995; 
Duprat et al., 1995; Velimirovic et al., 1996). We examined the TPNQ dose-response of 
heteromeric channels. Contrary to our hypothesis, there was no statistically significant 
difference in IC50 values between the homomeric GIRK2 and heteromeric GIRK1/GIRK2 
channels, IC50 = 14.82 nM and 18.71 nM, respectively (Fig. 12A and B).  
Effects of the GIRK1 on the TPNQ sensitivity of the heterotetrameric 
GIRK1/GIRK2 E127A mutant channels 
We next tested the heteromeric GIRK1/GIRK2 channels with the E127A 
mutation; however, we failed to see detectable basal currents (data not shown). The Gβγ 
activation showed us a small but significant enhancement in terms of the current size in 
the basal current of the heteromeric GIRK1/GIRK2_E127A mutant channels (Fig. 13B 
and C), which confirms the presence of surface expression of the E127A mutant 
channels, whereas the heteromeric wild-type channels showed a large enhancement in the 
basal current (Fig. 13A and C). Again, these challenges in distinguishing basal currents of 
the E127A mutant channels from endogenous background ones led us to utilize the 
GIRK2 E152D channels. 
Effects of the GIRK1 subunits on the TPNQ sensitivity of the heterotetrameric 
Kir3.1/Kir3.2 E152D channels 
Fig. 14 shows the current traces of the homomeric and heteromeric GIRK2 
E152D channels. The heteromeric GIRK1/GIRK2 E152D channels conduct much larger 
basal currents, -14.02 µA (Fig. 14 B and C) than the wild-type heteromeric 
GIRK1/GIRK2 channels do, -2.18 µA (Fig. 11B and C). In addition, the heteromeric 
GIRK1/GIRK2 E152D channels, IC50 = -17.81 nM, did not show a statistically 
significant difference in TPNQ sensitivity from the homomeric GIRK2 E152D channels, 
IC50 = -18.3 nM (Fig. 15A and B), a similar pattern to what we observed with the wild-
type channels (Fig. 12A and B).  
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Figure 11. Characteristic enhancement in the basal currents by the coexpression of GIRK1 and 
GIRK2 subunits. Representative current traces of A. GIRK2 wild-type B. heteromeric GIRK1/GIRK2 
channels. 2 ng of cRNA from each subunit were coinjected for coexpression. Currents through the channels 
were elicited with the same protocol as described in Fig. 3. The black current trace indicates the maximum 
basal current in ND96K (High K+) solution. The red current trace indicates the remaining current in High 
K+ solution containing 10 nM TPNQ. Dotted lines indicate the zero current level. C. Summary bar graphs 
of mean currents (mean ± SEM.). Approximately 2-fold increase in the basal currents was observed in the 
heteromeric GIRK1/GIRK2 compared with that of the homomeric GIRK2 channels. 
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Figure 12. No significant decrease in the TPNQ sensitivity due to the addition of the GIRK1 subunits, 
TPNQ insensitive subunits, in the heteromeric GIRK1/GIRK2 wild-type channels. A. Fraction of the 
unblocked channel currents (mean ± SEM., n ≥ 4) plotted against TPNQ concentration. The same 
normalization method was used as described in Fig. 4. B. Summary bar graphs of IC50 values (mean ± 
SEM.). IC50 values were obtained using the same Hill fitting described in Fig. 4. Two sample t-tests were 
carried out to assess significant differences in IC50 values between the GIRK2 wild-type and heteromeric 
GIRK1/GIRK2 channels (n.s. indicates no significance). 
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Figure 13. Basal current enhancement by coexpression of Gβγ with the heteromeric GIRK1/GIRK2 
in the presence and absence of the E127A mutation. Representative current traces of A. the heteromeric 
GIRK1/GIRK2 wild-type B. the heteromeric GIRK1/GIRK2 E127A mutant channels. 2 ng of cRNA of 
each corresponding subunit were coinjected for coexpression. All tested channels were coinjected with 2 ng 
of Gβ1 and 2ng of Gγ2 cRNAs. Currents through the channels were elicited with the same protocol as 
described in Fig. 3. The black current trace indicates the maximum basal current in ND96K (High K+) 
solution. The red current trace indicates the remaining current in High K+ solution containing 100 nM 
TPNQ. The grey current trace indicates the leak currents, currents remaining in the presence of 3 mM 
Barium Chloride. Dotted lines indicate the zero current levels. C. Summary bar graphs (mean ± SEM) of 
the mean currents of the channels. In panel C, uninjected oocytes were used as the negative control. Two 
sample t-tests were carried out to assess significant differences between the mean currents of the 
heteromeric GIRK1 with GIRK2 wild-type or the E127A mutant and uninjected oocytes (*** indicates 
p<0.0001).  
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Figure 14.  Mean currents of the coexpressed GIRK1 and GIRK2 E152D subunits. Representative 
current traces of A. GIRK2 E152D B. Heteromeric GIRK1/GIRK2 E152D channels. Currents through the 
channels were elicited with the same protocol as described in Fig. 3. The black current trace indicates the 
maximum basal current in ND96K (High K+) solution. The red current trace indicates the remaining current 
in High K+ solution containing 10 nM TPNQ. Dotted lines indicate the zero current level. C. Summary bar 
graphs of mean currents (mean ± SEM.).  
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Figure 15. No significant decrease in the TPNQ sensitivity of GIRK2 E152D channels in the presence 
or absence of the TPNQ-insensitive GIRK1 subunits. A. Fraction of the unblocked channel currents 
(mean ± SEM., n ≥ 4) plotted against the TPNQ concentration. The same normalization method was used 
as described in Fig. 4. B. Summary bar graphs of IC50 values (mean ± SEM.). IC50 values were obtained 
using the same Hill fitting as described in Fig. 4. Two sample t-tests were carried out to assess significant 
differences in IC50 values between the GIRK2 E152D and the heteromeric GIRK1/GIRK2 E152D channels 
(n.s. indicates no significance). 
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Additional effects of the GIRK1 subunits and the E127A mutation on TPNQ 
sensitivity  
Consequently, we conducted the TPNQ dose-response of the heteromeric 
GIRK1/GIRK2 E152D with E127A mutant channels. Fig. 16 shows examples of current 
traces of the homomeric and heteromeric GIRK2 E152D channels and their mutant 
channels. The reduction effect of the E127A mutation was also seen in the basal currents 
of the heteromeric GIRK1/GIRK2 E152D_E127A mutant channels, about a 2-fold 
decrease from the currents in the absence of the mutation (Fig. 16D).  
Fig. 17 shows the summary of TPNQ sensitivity of the homomeric and 
heteromeric GIRK2 E152D channels and their E127A mutant channels.  The TPNQ 
sensitivity of the heteromeric GIRK1/GIRK2 E152D_E127A mutant channels, IC50 = 
317.77 nM, reflects the additive effects of the Kir3.1 subunits and the E127A mutation as 
compared with the homomeric GIRK2 E152D channels, IC50 = 18.3 nM. As the effect of 
adding the GIRK1 subunits, there is 1.7-fold decrease in TPNQ sensitivity between the 
homomeric GIRK2 E152D_E127A channels, IC50 = 194.03 nM, and their heteromeric 
channels, IC50 = 317.77 nM, though there are no statistically significant effects of GIRK1 
subunits as the same patterns are consistently shown in the cases of the wild-type and 
E152D mutant channels. And as previously reported, there is a 10-fold decrease in the 
TPNQ sensitivity between the homomeric GIRK2 E152D and its E127A mutant 
channels, which reflects the effect of E127A mutation (Fig. 17B). Overall, an 
approximate 18-fold increase in IC50 values is shown in the heteromeric GIRK1/GIRK2 
E152D_E127A compared with the homomeric GIRK2 E152D. 
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Figure 16. Examples of current traces that show the inhibition of the homomeric and the heteromeric 
GIRK2 E152D by 10 nM TPNQ in the presence and absence of the E127A mutation. Representative 
current traces of A. homomeric GIRK2 E152D B. Heteromeric GIRK1/GIRK2 E152D C and D in the 
presence of the E127A mutation of the channels in A and B, respectively. 2 ng of cRNA from each 
corresponding subunit was coinjected for coexpression. Currents through the channels were elicited with 
the same protocol as described in Fig. 3. The black current trace indicates the maximum basal current in 
ND96K (High K+) solution and the red current trace indicates the remaining current in High K+ solution 
containing 10 nM TPNQ. Dotted lines indicate the zero current level. 
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Figure 17. Additional effect of the GIRK1 subunits and the E127A mutation on TPNQ block of 
GIRK2 (E152D) currents. A. Fraction of the unblocked channel currents (mean ± SEM., n ≥ 4) plotted 
against the TPNQ concentration. Same normalization method was used as described in Fig. 4. B. Summary 
bar graphs of IC50 values (mean ± SEM). IC50 values were obtained using the same Hill fitting as described 
in Fig. 4. Two sample t-tests were carried out to assess significant differences in IC50 values between the 
homomeric GIRK2 E152D and the heteromeric GIRK1/GIRK2 E152D in the presence of the E127A 
mutation (n.s. indicates no significance).  The grey dashed line indicates the remaining mean currents of the 
channels in the presence of 10 nM TPNQ. Additive effects are shown in the TPNQ sensitivity of the 
heteromeric GIRK1/GIRK2 E152D_E127A compared with that of the homomeric GIRK2 E152D. There is 
an approximately 18-fold difference between them, which appears to be contributed by the GIRK1 subunits 
(~1.7 fold) and the E127A mutation (10-fold). 
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DISCUSSION AND FUTURE DIRECTIONS 
 The goal of this study was to experimentally validate the predictions made by 
Sundaram’s in silico alanine mutagenesis simulations of the TPNQ docked 
ROMK1_IRK2 (Fig. 2A) and GIRK2 models (Fig. 2B). The focus was on the specific 
paired residue interactions in order to test whether differences in the interaction energies 
could guide the design of specific TPN molecules to specifically block the channel of 
interest. In this study, we examined the relative contribution of two predicted residues, 
E123 and E151, in the ROMK1 and TPNQ. We also determined whether the pore helix 
mutant channel, GIRK2 E152D, previously reported to enhance basal currents (Yi et al., 
2001) could serve as a good representative of the GIRK2 wild-type channel, particularly 
for TPNQ studies. Moreover, we determined the TPNQ sensitivity of the GIRK2 and the 
heteromeric GIRK1/GIRK2 channels in the dose-dependent manner to test the 
contribution of the GIRK1 subunits in the interaction of the heteromeric channel with 
TPNQ.  
Consistent with previous reports (Jin et al., 1999) and computational predictions 
(Sundaram et al., unpublished), the homomeric ROMK1 E123A mutant channel showed 
a significant reduction in TPNQ sensitivity by more than 2-fold as compared to the wild 
type (Fig. 4A and B). Another predicted mutation, E151A, did not express detectable 
ionic currents, as previously reported by Lu’s group (Jin et al., 1999). However, the 
coinjection method conferred the measurable currents of the coinjected E151A and wild-
type channels. This indicates that there are heteromeric channels expressed with various 
combinations between the wild-type and E151A mutant subunits.  
Furthermore, the coinjection method allowed us to directly compare the IC50 
values of two coinjected mutant channels so that we could find out the relative 
contributions of each residue in the interaction between the ROMK1 and the TPNQ. Even 
though we might have expected a greater decrease in TPNQ sensitivity of ROMK1 by the 
E123A mutation than the E151A, since E123 has a greater number of high energy 
interactions with TPNQ residues than E151 (Fig. 2A), our results countered our 
expectations as there was no significant difference in the TPNQ sensitivity between the 
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two coinjected mutant channels (Fig. 3B). We may infer from the statistical results that 
E123 and E151 make a similar level of contribution to the paired interactions of ROMK1 
with TPNQ.  
According to alanine scanning mutagenesis studies by Lu’s group (Jin et al., 
1999), the effect of mutation of E123 was not particularly larger than mutations of other 
allosteric interaction sites. We suspected that the effect of our predicted mutations on 
binding interaction is probably compensated by the presence of several other strong 
allosteric interaction sites. We may test this by double mutating both residues and see 
how much of total interaction energies are contributed by the direct paired interactions. 
We were able to see a much more remarkable effect of the predicted mutation, 
E127A (Fig. 2B), on the TPNQ sensitivity of the GIRK2 channels. However, we had to 
overcome a few experimental barriers. First, the basal currents of the GIRK2 wild-type 
were very small, ranging from -0.4 to -0.7 µA (data not shown), making it difficult to 
distinguish the true basal currents conducted by the target channel from the background 
endogenous currents, ranging from -0.2 to -0.5 µA (data not shown) and also hard to see 
the TPNQ inhibition of the channel in a dose-dependent manner.  
The other problem was that the E127A mutation appeared to cause the reduction 
of the basal currents compared to wild-type controls. In both the homomeric GIRK2 
wild-type and the heteromeric GIRK1/GIRK2 channels in the presence of the E127A 
mutation, the basal currents were not distinguishable from those of the uninjected oocytes 
(data not shown). In the case of the homomeric GIRK2 wild-type channels, the current 
was not detectable even with Gβγ stimulation (Fig. 8B and E; Fig. 13B and C), while the 
basal currents of both homomeric and heteromeric channels without the E127A mutation 
were dramatically increased by Gβγ stimulation (Fig. 8B). These Gβγ stimulation tests 
suggest that the E127A mutation affects the basal currents probably either by an effect on 
the surface expression or by affecting the gating properties of the channel.  
In order to overcome the above experimental barriers, we examined a pore helix 
mutant GIRK2 E152D, previously reported to enhance basal currents by about 20-fold by 
altering only the channel gating properties (Yi et al., 2001). In our hands, this mutant also 
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dramatically enhanced basal currents by 20-fold compared with the wild-type channel 
(Fig. 6C). Also, the comparison of TPNQ sensitivity showed no significant difference 
between the GIRK2 wild-type and the E152D channels (Fig. 7A and B). Surprisingly, 
Gβγ stimulation produced large measurable currents of the GIRK2 E152D_E127A 
mutant channel (Fig. 8D and F) whereas there were almost no measurable basal currents 
in the GIRK2 E127A (Fig. 8B and E). The Gβγ stimulation tests also showed a 
remarkable effect on the TPNQ sensitivity of the E127A mutation.  The inhibition of the 
GIRK2 E152D_E127A by 100 nM TPNQ was significantly reduced compared to the 
GIRK2 E152D (Fig. 8F). Therefore, the large basal currents and the similarity in the 
TPNQ sensitivity made the GIRK2 E152D mutant a good representative of the wild-type 
particularly for TPNQ studies. 
Interestingly, further comparisons of the mean currents among homomeric and 
heteromeric GIRK2 E152D channels in the absence and presence of the E127A mutation 
showed a consistent 2-fold reduction of currents for E127A mutants (Fig. 9C; Fig. 16C 
and D). These results suggest that the E127A mutation caused a reduction in the basal 
currents probably by either altering the gating properties of the channel or reducing the 
surface expression level of the mutant channel.  
Furthermore, as shown in Fig. 16, the ~2-fold reduction of basal currents in the 
GIRK2 E152D_E127A in both homomeric and heteromeric forms was not as dramatic as 
that of their wild-type ones, which showed almost no detectable basal currents even under 
Gβγ stimulation (Fig. 8B and E; Fig. 8B and C). This may indicate that the effect of the 
E152D mutation, which enhances the basal currents by altering gating properties, 
compensates for the reduction effect of E127A to some extent. 
As predicted by the in silico studies, the TPNQ dose-dependence results from 
GIRK2 E152D_E127A showed a remarkable decrease, greater than 10-fold, in TPNQ 
sensitivity, which is consistent with the Gβγ stimulation studies (Fig. 8F). This supports 
our hypothesis that E127A is a critical interacting residue in the GIRK2/TPNQ interface, 
since it interacts with 5 residues on all four subunits (Fig. 2B) and is the one of the 
residues that reveals the largest effect of the mutation on TPNQ sensitivity. 
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We also tested the effect of adding GIRK1 (relatively TPNQ insensitive) subunits 
on the TPNQ sensitivity of GIRK2 subunits, since when both subunits are coexpressed 
they form heteromeric GIRK1/GIRK2 channels. Contrary to our expectation, the addition 
of the GIRK1 subunits did not significantly shift the TPNQ sensitivity from the 
homomeric GIRK2 (Fig. 12B). The GIRK2 in the background of E152D also showed no 
significant difference between the homomeric and the heteromeric channels (Fig. 15B), 
which offers another supportive piece of evidence to show its similarity to the wild-type. 
This implies that less than four GIRK2 subunits, are sufficient to confer a similar level of 
TPNQ sensitivity to what the four sensitive subunits can confer.  
Interestingly, the additional effects of the E127A mutation and the GIRK1 
subunits were found in the GIRK1/GIRK2 E152D with the E127A mutation (Fig. 17B). 
There was an approximate 18-fold increase in the IC50 values in the heteromeric 
GIRK1/GIRK2 E152D_E127A channel compared with the homomeric GIRK2 E152D 
channel. This may indicate that approximately a 1.7-fold increase in IC50 values was 
contributed by the GIRK1 subunits and about a 10-fold increase in IC50 values was 
contributed by the E127A mutation.  
Earlier we considered that less than four sensitive subunits may be sufficient to 
confer TPNQ sensitivity at a level similar to that of homotetrameric channels. However, 
it appears that when the sensitive subunits lose critical residues, such as with the E127A 
mutation, which causes a further loss of TPNQ sensitivity, the effect of the Kir3.1 subunit 
is more pronounced as shown in the heteromeric GIRK1/GIRK2 E152D_E127A channel 
compared with the homomeric GIRK2 E152D channel.  
Could we apply what we have learned from our study to design specific blockers 
for Kir channels? Knowing the interacting pairs of residues can serve as a strong starting 
point in designing specific blocker for Kir channels in terms of efficiency in the cost and 
labor. For example, if we wish to design a specific blocker that has higher selectivity for 
ROMK1 over GIRK2, we could synthesize substitutions in Arginine 7 and Lysine 20 of 
TPNQ to decrease its selectivity for GIRK2 since these residues do not appear to be 
critical for the ROMK1 interaction with TPNQ (Fig. 2). Or, if we wish to produce a 
blocker that is more selective for the GIRK2 over the ROMK1, we could decrease the 
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TPNQ sensitivity of the ROMK1 by substituting Lysine17 on TPNQ, since it interacts 
with two residues on ROMK1 that confer the two highest interaction energies while 
Lysine 17 with E127 of GIRK2 shows a relatively smaller interaction energy. The 
specific residue substitutions in TPNQ would be tested first in silico with our 
computational models to determine which residue substitutions would produce the best 
candidates to test experimentally. 
However, the residues predicted by docking simulations (Sundaram et al., 
unpublished) change the TPNQ sensitivity only by 2-fold in ROMK1 E123A mutant and 
10-fold in GIRK2 E127A mutant. To design a practical specific inhibitor, selectivity 
greater than 100-fold is required in order to achieve sufficiently selective inhibition of a 
target channel current (Ramu et al., 2008). Double mutation of TPN (H12L-M13Q), 
referred to as TPNLQ, made a toxin specific for ROMK1 over GIRK1/GIRK4 by greater 
than 250-fold (Ramu et al, 2008). This may suggest that we also need to select the 
residues that are interacting with the allosteric interaction sites and test more various 
combinations of substitutions to increase the selectivity.   
This type of structure-function study suggests an efficient and cost effective way 
toward design and development of specific Kir channel blockers by focusing on specific 
paired interactions between TPNQ and the Kir channels. 
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